MTOR and familial pancreatic carcinoma: mTOR signaling has emerged as a target for therapy; e also conducted a retrospective study in patients of pancreatic cancer with diabeteshowever, most clinical trials of mTOR inhibitors have been disappointing, which may be because mTOR mediated potent negative feedback loops.